Stocks Health care LNSR
NASDAQ · Health careLENSAR, Inc. (LNSR)
LENSAR, Inc. brought in $60.3M of revenue over the twelve months to June 30, 2026, up 3.3% from a year earlier. Net income was $34.7M, a net margin of 57.6%. In fiscal 2025 capital spending exceeded operating cash flow by $14.9M. At June 30, 2026 it held $13.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about LENSAR, Inc.
- Net worth
- LENSAR, Inc. has a market value (market cap) of $67.1M at the latest share price, and shareholders' equity of $14.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $58.4M (+9.2% year on year), with a net loss of $34.3M. Over the 12 months to June 30, 2026: revenue $60.3M, net income $34.7M.
- Cash flow
- In fiscal 2025 operations used $14.8M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- LENSAR, Inc.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.
What LENSAR, Inc. does
LENSAR, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LNSR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $58.4M | -$34.3M | -$2.87 | -$14.9M |
| 2024 | $53.5M | -$31.4M | -$2.73 | -$2.4M |
| 2023 | $42.2M | -$14.4M | -$1.31 | -$9.9M |
| 2022 | $35.4M | -$19.9M | -$1.96 | -$15M |
| 2021 | $34.5M | -$19.6M | -$2.09 | -$9.3M |
| 2020 | $26.4M | -$19.8M | -$4.28 | -$14.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where LNSR ranks in Health care
Latest SEC filings
What LENSAR, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 18% to $16.5M versus the same quarter last year; diluted EPS $0.10 versus -$0.15.
- August 13, 2026
- August 10, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- June 23, 2026Additional proxy material DEFA14A
- June 23, 2026
- June 23, 2026Proxy statement DEF 14A
- June 2, 2026
- May 29, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running LENSAR, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 3, 2026 | Link William J PhdDirector | Received as pay | 17,421 | - |
| June 3, 2026 | Lindstrom Richard L MdDirector | Received as pay | 17,421 | - |
| June 3, 2026 | Winer Gary MDirector | Received as pay | 17,421 | - |
| June 3, 2026 | O'Farrell Elizabeth G.Director | Received as pay | 17,421 | - |
| June 3, 2026 | Weisner Aimee SDirector | Received as pay | 17,421 | - |
| June 3, 2026 | Curtis Nicholas TChief Executive Officer, Director | Received as pay | 130,662 | - |
| June 3, 2026 | Connaughton Alan B.Chief Operating Officer | Received as pay | 34,843 | - |
| June 3, 2026 | Wong KendraPrincipal Accounting Officer | Received as pay | 13,066 | - |
Who owns LNSR
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Ellis Thomas B13D, may seek influence with 5 related filers | 55.9% | March 25, 2025 |
| Brandes Investment Partners, LP13G, passive | 8.5% | May 14, 2026 |
| Nicholas T. Curtis13G, passive | 8.5% | May 13, 2025 |
Largest institutional holders
Insiders
11 insiders reported holding 2,970,451 shares in total, about $16.2M at the last price.
| Holder | Shares |
|---|---|
| Curtis Nicholas TChief Executive Officer, Director | 1,122,758 |
| Link William J PhdDirector | 568,062 |
| Connaughton Alan B.Chief Operating Officer | 389,173 |
| Lindstrom Richard L MdDirector | 263,831 |
| Staab Thomas R IIChief Financial Officer | 174,609 |
| Weisner Aimee SDirector | 110,368 |
| Winer Gary MDirector | 105,635 |
| O'Farrell Elizabeth G.Director | 67,368 |
| Wong KendraPrincipal Accounting Officer | 56,481 |
| Hammer Todd BDirector, 10% owner | 56,083 |
Questions about LNSR
What does LENSAR, Inc. do?
LENSAR, Inc. is a company in the Health care sector, listed on NASDAQ as LNSR. Its shares trade on NASDAQ under the ticker LNSR.
What is LENSAR, Inc.'s net worth?
LENSAR, Inc. has a market value (market cap) of $67.1M at the latest share price, and shareholders' equity of $14.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is LENSAR, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $34.7M on revenue of $60.3M, a net margin of 57.6%.
How much revenue does LENSAR, Inc. make?
Over the twelve months to June 30, 2026 LENSAR, Inc. reported revenue of $60.3M. That is 3.3% more than a year earlier.
When did LENSAR, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.
When is LENSAR, Inc.'s next earnings report?
LENSAR, Inc.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.
Similar companies
Compare LNSR with
Follow LNSR
Get an email when LENSAR, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values LENSAR, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.